BETHESDA, MD -- (Marketwired) -- 09/26/14 -- Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), a developer of advanced medical cannabis therapies, announces that it has achieved Good Manufacturing Practices (GMP) capabilities as the Company moves toward the launch of its first clinical study of Cannabics SR capsules.
GMP regulations are designed to ... read more
Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that the
Company has made two key appointments to the Company's Advisory Board
with the recent recruitment of Mr. Ika Abravanel ... read more